Clinical presentation and pathophysiology of gastroparesis

Gastroenterology Clinics of North America

Volumn 44, Issue 1, 2015, Pages 21-30

  Nguyen, Linda Anh ^a   Snape, William J ^b  

^a STANFORD UNIVERSITY   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

Gastric accommodation; Gastric emptying; Gastric motor function; Gastroparesis; Pathophysiology; Visceral hypersensitivity

Indexed keywords

BUSPIRONE; CISAPRIDE; CLONIDINE; PAROXETINE; SILDENAFIL; TEGASEROD;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ANOREXIA; ANTRAL HYPOMOTILITY; AUTONOMIC DYSFUNCTION; BLOATING; DELAYED GASTRIC EMPTYING; DISEASE SEVERITY; DUODENAL DYSMOTILITY; DYSPEPSIA; HUMAN; HYPERSENSITIVITY; NAUSEA; NAUSEA AND VOMITING; PATHOGENESIS; PYLOROSPASM; REVIEW; STOMACH DISEASE; STOMACH EMPTYING; STOMACH MOTILITY; STOMACH PARESIS; SYMPTOMATOLOGY; VISCERAL HYPERSENSITIVITY; VOMITING; GASTROPARESIS; PATHOPHYSIOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX;

ABDOMINAL PAIN; DYSPEPSIA; GASTRIC EMPTYING; GASTROPARESIS; HUMANS; NAUSEA; SEVERITY OF ILLNESS INDEX; VOMITING;

EID: 84922955938     PISSN: 08898553     EISSN: 15581942     Source Type: Journal    
DOI: 10.1016/j.gtc.2014.11.003     Document Type: Review

References (53)

1. Parkman H.P., Hasler W.L., Fisher R.S. American Gastroenterological Association medical position statement: diagnosis and treatment of gastroparesis. Gastroenterology 2004, 127(5):1589-1591.
2. Soykan I., Sivri B., Sarosiek I., et al. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci 1998, 43(11):2398-2404.
3. Parkman H.P., Yates K., Hasler W.L., et al. Similarities and differences between diabetic and idiopathic gastroparesis. Clin Gastroenterol Hepatol 2011, 9(12):1056-1064. [quiz: e133-4].
4. Hoogerwerf W.A., Pasricha P.J., Kalloo A.N., et al. Pain: the overlooked symptom in gastroparesis. Am J Gastroenterol 1999, 94(4):1029-1033.
5. Parkman H.P., Yates K., Hasler W.L., et al. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Gastroenterology 2011, 140(1):101-115.
6. Sarnelli G., Caenepeel P., Geypens B., et al. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol 2003, 98(4):783-788.
7. Stanghellini V., Tosetti C., Paternico A., et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996, 110(4):1036-1042.
8. Parkman H.P., Yates K., Hasler W.L., et al. Cholecystectomy and clinical presentations of gastroparesis. Dig Dis Sci 2013, 58(4):1062-1073.
9. Pasricha P.J., Colvin R., Yates K., et al. Characteristics of patients with chronic unexplained nausea and vomiting and normal gastric emptying. Clin Gastroenterol Hepatol 2011, 9(7):567-576.e1-4.
10. Hasler W.L., Wilson L.A., Parkman H.P., et al. Factors related to abdominal pain in gastroparesis: contrast to patients with predominant nausea and vomiting. Neurogastroenterol Motil 2013, 25(5):427-438.
11. Rentz A.M., Kahrilas P., Stanghellini V., et al. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res 2004, 13(10):1737-1749.
12. Revicki D.A., Rentz A.M., Dubois D., et al. Development and validation of a patient-assessed gastroparesis symptom severity measure: the gastroparesis cardinal symptom index. Aliment Pharmacol Ther 2003, 18(1):141-150.
13. Hasler W.L., Parkman H.P., Wilson L.A., et al. Psychological dysfunction is associated with symptom severity but not disease etiology or degree of gastric retention in patients with gastroparesis. Am J Gastroenterol 2010, 105(11):2357-2367.
14. Wood J.D., Alpers D.H., Andrews P.L. Fundamentals of neurogastroenterology. Gut 1999, 45(Suppl 2):II6-II16.
15. Kindt S., Tack J. Impaired gastric accommodation and its role in dyspepsia. Gut 2006, 55(12):1685-1691.
16. Camilleri M., Malagelada J.R., Brown M.L., et al. Relation between antral motility and gastric emptying of solids and liquids in humans. Am J Physiol 1985, 249(5 Pt 1):G580-G585.
17. Takahashi T. Interdigestive migrating motor complex -its mechanism and clinical importance. JSmooth Muscle Res 2013, 49:99-111.
18. Azpiroz F. Control of gastric emptying by gastric tone. Dig Dis Sci 1994, 39(Suppl 12):18S-19S.
19. Carbone F., Tack J. Gastroduodenal mechanisms underlying functional gastric disorders. Dig Dis 2014, 32(3):222-229.
20. Thumshirn M., Camilleri M., Choi M.G., et al. Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans. Gastroenterology 1999, 116(3):573-585.
21. Kerlin P. Postprandial antral hypomotility in patients with idiopathic nausea and vomiting. Gut 1989, 30(1):54-59.
22. Camilleri M., Brown M.L., Malagelada J.R. Relationship between impaired gastric emptying and abnormal gastrointestinal motility. Gastroenterology 1986, 91(1):94-99.
23. Barnett J.L., Owyang C. Serum glucose concentration as a modulator of interdigestive gastric motility. Gastroenterology 1988, 94(3):739-744.
24. Mearin F., Camilleri M., Malagelada J.R. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 1986, 90(6):1919-1925.
25. Ezzeddine D., Jit R., Katz N., et al. Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis. Gastrointest Endosc 2002, 55(7):920-923.
26. Miller L.S., Szych G.A., Kantor S.B., et al. Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle. Am J Gastroenterol 2002, 97(7):1653-1660.
27. Arts J., Holvoet L., Caenepeel P., et al. Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis. Aliment Pharmacol Ther 2007, 26(9):1251-1258.
28. Friedenberg F.K., Palit A., Parkman H.P., et al. Botulinum toxin A for the treatment of delayed gastric emptying. Am J Gastroenterol 2008, 103(2):416-423.
29. Fraser R.J., Horowitz M., Maddox A.F., et al. Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis-effects of cisapride. Gut 1994, 35(2):172-178.
30. Sullivan S.D., Hanauer J., Rowe P.C., et al. Gastrointestinal symptoms associated with orthostatic intolerance. JPediatr Gastroenterol Nutr 2005, 40(4):425-428.
31. Camilleri M., Coulie B., Tack J.F. Visceral hypersensitivity: facts, speculations, and challenges. Gut 2001, 48(1):125-131.
32. Kumar A., Attaluri A., Hashmi S., et al. Visceral hypersensitivity and impaired accommodation in refractory diabetic gastroparesis. Neurogastroenterol Motil 2008, 20(6):635-642.
33. Horowitz M., Su Y.C., Rayner C.K., et al. Gastroparesis: prevalence, clinical significance and treatment. Can J Gastroenterol 2001, 15(12):805-813.
34. Talley N.J., Verlinden M., Jones M. Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia?. Am J Gastroenterol 2001, 96(5):1422-1428.
35. Karamanolis G., Caenepeel P., Arts J., et al. Determinants of symptom pattern in idiopathic severely delayed gastric emptying: gastric emptying rate or proximal stomach dysfunction?. Gut 2007, 56(1):29-36.
36. Talley N.J., Verlinden M., Snape W., et al. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 2000, 14(12):1653-1661.
37. Silvers D., Kipnes M., Broadstone V., et al. Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA-5 Study Group. Clin Ther 1998, 20(3):438-453.
38. Arts J., Caenepeel P., Verbeke K., et al. Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying. Gut 2005, 54(4):455-460.
39. Harrell S.P., Studts J.L., Dryden G.W., et al. Anovel classification scheme for gastroparesis based on predominant-symptom presentation. JClin Gastroenterol 2008, 42(5):455-459.
40. Urayama Y., Yamada Y., Nakamura E., et al. Electrical and chemical stimulation of the nucleus raphe magnus inhibits induction of retching by afferent vagal fibers. Auton Neurosci 2010, 152(1-2):35-40.
41. Tack J., Piessevaux H., Coulie B., et al. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998, 115(6):1346-1352.
42. Tack J., Janssen P., Masaoka T., et al. Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia. Clin Gastroenterol Hepatol 2012, 10(11):1239-1245.
43. Sarnelli G., Sifrim D., Janssens J., et al. Influence of sildenafil on gastric sensorimotor function in humans. Am J Physiol Gastrointest Liver Physiol 2004, 287(5):G988-G992.
44. Tack J., Broekaert D., Coulie B., et al. Influence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in humans. Aliment Pharmacol Ther 2003, 17(4):603-608.
45. Tack J., Broekaert D., Coulie B., et al. The influence of cisapride on gastric tone and the perception of gastric distension. Aliment Pharmacol Ther 1998, 12(8):761-766.
46. Tack J., Janssen P., Bisschops R., et al. Influence of tegaserod on proximal gastric tone and on the perception of gastric distention in functional dyspepsia. Neurogastroenterol Motil 2011, 23(2):e32-e39.
47. Van Oudenhove L., Kindt S., Vos R., et al. Influence of buspirone on gastric sensorimotor function in man. Aliment Pharmacol Ther 2008, 28(11-12):1326-1333.
48. Jiang X., Locke G.R., Choung R.S., et al. Prevalence and risk factors for abdominal bloating and visible distention: a population-based study. Gut 2008, 57(6):756-763.
49. Hasler W.L., Wilson L.A., Parkman H.P., et al. Bloating in gastroparesis: severity, impact, and associated factors. Am J Gastroenterol 2011, 106(8):1492-1502.
50. Anaparthy R., Pehlivanov N., Grady J., et al. Gastroparesis and gastroparesis-like syndrome: response to therapy and its predictors. Dig Dis Sci 2009, 54(5):1003-1010.
51. Troncon L.E., Bennett R.J., Ahluwalia N.K., et al. Abnormal intragastric distribution of food during gastric emptying in functional dyspepsia patients. Gut 1994, 35(3):327-332.
52. Agrawal A., Houghton L.A., Lea R., et al. Bloating and distention in irritable bowel syndrome: the role of visceral sensation. Gastroenterology 2008, 134(7):1882-1889.
53. Agrawal A., Houghton L.A., Reilly B., et al. Bloating and distension in irritable bowel syndrome: the role of gastrointestinal transit. Am J Gastroenterol 2009, 104(8):1998-2004.